Trulieve swings to Q3 net profit of $800,000 year over year
Trulieve Cannabis reported third-quarter net income attributable to common shareholders of $900,000, while revenue fell 20% year over year to $230.2 million. It also received final DEA registrations for state-licensed medical marijuana dispensaries and repaid $65 million in mortgage notes.
1. Quarterly results
Trulieve Cannabis reported third-quarter 2026 net income attributable to common shareholders of $900,000, compared with a loss a year earlier. Revenue fell 20% year over year to $230.2 million. The quarter included only medical operations, compared with previously consolidated operations.
2. Registrations and debt
The company received final DEA registrations for state-licensed medical marijuana dispensaries following rescheduling to Schedule III. It also repaid $65 million in mortgage notes payable ahead of their 2028 maturity, saying the repayment would reduce leverage and interest expense.
